The diagnostic and prognostic potential of the EGFR/MUC4/MMP9 axis in glioma patients
Abstract Glioblastoma is the most aggressive form of brain cancer, presenting poor prognosis despite current advances in treatment. There is therefore an urgent need for novel biomarkers and therapeutic targets. Interactions between mucin 4 (MUC4) and the epidermal growth factor receptor (EGFR) are...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Portfolio
2022-11-01
|
| Sarja: | Scientific Reports |
| Linkit: | https://doi.org/10.1038/s41598-022-24099-4 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|